{"entity":{"type":"insider","cik":"0001826263","url":"/insider/0001826263","json_url":"/insider/0001826263.json","name":"Vakiener Victoria","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":7,"first":"2021-01-27","last":"2025-12-23","span_basis":"filed_date"},"name_variants":[{"name":"Vakiener Victoria","source":"filing","n_filings":7,"first_seen":"2021-01-27","last_seen":"2025-12-23"}],"transactions":[{"id":5178944,"accession":"0001826263-25-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001826263-25-000006","line_url":"/filing/0001826263-25-000006","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001826263","owner_name":"Vakiener Victoria","owner_display_name":"Vakiener Victoria","owner_url":"/insider/0001826263","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10040.0,"shares_display":"10,040","price_per_share":67.6784203187251,"price_display":"67.68","price_state":"stated","total_value":679491.34,"total_display":"679,491.34","total_whole":"679,491","shares_owned_after":37683.0,"shares_owned_after_display":"37,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-19","filed_date":"2025-12-23","scope":"insider","n_lines":3},{"id":2491478,"accession":"0001628280-24-051923","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-051923","line_url":"/filing/0001628280-24-051923#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001826263","owner_name":"Vakiener Victoria","owner_display_name":"Vakiener Victoria","owner_url":"/insider/0001826263","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8994.0,"shares_display":"8,994","price_per_share":21.91,"price_display":"21.91","price_state":"stated","total_value":197058.54,"total_display":"197,058.54","total_whole":"197,059","shares_owned_after":21211.0,"shares_owned_after_display":"21,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-18","scope":"insider"},{"id":2829688,"accession":"0001628280-24-020774","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-020774","line_url":"/filing/0001628280-24-020774#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001826263","owner_name":"Vakiener Victoria","owner_display_name":"Vakiener Victoria","owner_url":"/insider/0001826263","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1799.0,"shares_display":"1,799","price_per_share":23.31,"price_display":"23.31","price_state":"stated","total_value":41934.69,"total_display":"41,934.69","total_whole":"41,935","shares_owned_after":30205.0,"shares_owned_after_display":"30,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-06","scope":"insider"},{"id":2325210,"accession":"0001628280-24-001422","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-001422","line_url":"/filing/0001628280-24-001422","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001826263","owner_name":"Vakiener Victoria","owner_display_name":"Vakiener Victoria","owner_url":"/insider/0001826263","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4720.0,"shares_display":"4,720","price_per_share":38.096059322033895,"price_display":"38.10","price_state":"stated","total_value":179813.4,"total_display":"179,813.40","total_whole":"179,813","shares_owned_after":33101.0,"shares_owned_after_display":"33,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-11","filed_date":"2024-01-16","scope":"insider","n_lines":2},{"id":8661564,"accession":"0001628280-23-033520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-033520","line_url":"/filing/0001628280-23-033520#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001826263","owner_name":"Vakiener Victoria","owner_display_name":"Vakiener Victoria","owner_url":"/insider/0001826263","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1550.0,"shares_display":"1,550","price_per_share":26.33,"price_display":"26.33","price_state":"stated","total_value":40811.5,"total_display":"40,811.50","total_whole":"40,812","shares_owned_after":21734.0,"shares_owned_after_display":"21,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-10-02","scope":"insider"},{"id":4866828,"accession":"0000899243-21-005029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-005029","line_url":"/filing/0000899243-21-005029#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001826263","owner_name":"Vakiener Victoria","owner_display_name":"Vakiener Victoria","owner_url":"/insider/0001826263","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":817.0,"shares_display":"817","price_per_share":11.21,"price_display":"11.21","price_state":"stated","total_value":9158.57,"total_display":"9,158.57","total_whole":"9,159","shares_owned_after":52685.0,"shares_owned_after_display":"52,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-04","filed_date":"2021-02-05","scope":"insider"},{"id":4350080,"accession":"0000899243-21-003532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-003532","line_url":"/filing/0000899243-21-003532#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001826263","owner_name":"Vakiener Victoria","owner_display_name":"Vakiener Victoria","owner_url":"/insider/0001826263","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":599.0,"shares_display":"599","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":6834.59,"total_display":"6,834.59","total_whole":"6,835","shares_owned_after":27982.0,"shares_owned_after_display":"27,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","url":"/issuer/0000879407","role":"Director","n_filings":5,"first_seen":"2023-10-02","last_seen":"2025-12-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Officer (Chief Commercial Officer)","n_filings":2,"first_seen":"2021-01-27","last_seen":"2021-02-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001826263","retrieved_at":"2026-08-26T18:06:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}